Medicare Enrolled
Dr. Beaula Koduri, MD
Hematology & Oncology · Edison, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koduri from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koduri?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koduri
Dr. Beaula Koduri is a hematology & oncology specialist in Edison, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Koduri performed 199,736 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Koduri received a total of $14,367 from 84 pharmaceutical and/or device companies across 834 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koduri is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 2% volume in NJ
$14,367 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗199,736
Medicare services
Top 2% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
173,221 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,580 | $6 | $27 |
| Anti-nausea injection (ondansetron/Zofran) | 4,093 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,701 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,664 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,148 | $8 | $25 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
1,552 | $0 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,274 | $78 | $170 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
912 | $58 | $160 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
634 | $27 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
480 | $99 | $240 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
470 | $13 | $60 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
467 | $50 | $100 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
305 | $123 | $319 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
204 | $1 | $2 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
204 | $7 | $170 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
158 | $102 | $230 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
123 | $138 | $370 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
105 | $26 | $70 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
103 | $61 | $150 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
92 | $1 | $20 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
91 | $1 | $7 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
61 | $0 | $1 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
47 | $99 | $250 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
35 | $91 | $240 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $151 | $450 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.8% high complexity
94.5% medium
3.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,367
Total received (2018-2024)
Avg $2,052/year across 7 years
Top 20% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
834
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,734
2023
$2,548
2022
$2,851
2021
$2,145
2020
$1,484
2019
$1,971
2018
$1,633
Payments by company (2024)
Incyte Corporation
$362
Astellas Pharma US Inc
$190
E.R. Squibb & Sons, L.L.C.
$130
Bayer Healthcare Pharmaceuticals Inc.
$120
Gilead Sciences, Inc.
$112
Janssen Biotech, Inc.
$106
Regeneron Healthcare Solutions, Inc.
$94
TAIHO ONCOLOGY, INC.
$73
Novartis Pharmaceuticals Corporation
$59
Eisai Inc.
$53
AstraZeneca Pharmaceuticals LP
$49
PUMA BIOTECHNOLOGY, INC.
$46
Tempus AI, Inc
$46
ABBVIE INC.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$37
Merck Sharp & Dohme LLC
$33
PharmaEssentia USA Corporation
$31
Emmaus Medical, Inc.
$26
Adaptive Biotechnologies Corporation
$25
EMD Serono, Inc.
$17
PFIZER INC.
$17
Lilly USA, LLC
$16
Azurity Pharmaceuticals, Inc.
$15
GlaxoSmithKline, LLC.
$14
Alnylam Pharmaceuticals Inc.
$14
Myriad Genetic Laboratories, Inc.
$14
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
Incyte Corporation
$1,492
E.R. Squibb & Sons, L.L.C.
$1,387
Novartis Pharmaceuticals Corporation
$1,303
Janssen Biotech, Inc.
$1,209
Astellas Pharma US Inc
$916
PFIZER INC.
$720
AstraZeneca Pharmaceuticals LP
$535
Amgen Inc.
$499
Celgene Corporation
$354
Genentech USA, Inc.
$345
Daiichi Sankyo Inc.
$316
Gilead Sciences, Inc.
$281
GENZYME CORPORATION
$275
Takeda Pharmaceuticals U.S.A., Inc.
$273
Alexion Pharmaceuticals, Inc.
$272
Regeneron Healthcare Solutions, Inc.
$257
Eisai Inc.
$247
Lilly USA, LLC
$240
Merck Sharp & Dohme LLC
$188
Bayer Healthcare Pharmaceuticals Inc.
$164
Merck Sharp & Dohme Corporation
$145
Bayer HealthCare Pharmaceuticals Inc.
$126
Medical Device Business Services, Inc.
$117
Emmaus Medical, Inc.
$115
Foundation Medicine, Inc.
$112
Janssen Pharmaceuticals, Inc
$108
GlaxoSmithKline, LLC.
$102
Seagen Inc.
$99
EISAI INC.
$95
GE HEALTHCARE
$93
Pharmacyclics LLC, An AbbVie Company
$83
BeiGene USA, Inc.
$79
GE HealthCare
$79
TAIHO ONCOLOGY, INC.
$73
Mirati Therapeutics, Inc.
$65
Adaptive Biotechnologies Corporation
$63
TESARO, Inc.
$61
MorphoSys, US Inc.
$61
EMD Serono, Inc.
$61
Epizyme, Inc.,
$60
Dova Pharmaceuticals
$57
Sandoz Inc.
$57
Exelixis Inc.
$56
ABBVIE INC.
$54
Heron Therapeutics, Inc.
$53
Mylan Institutional Inc.
$51
Organon LLC
$49
Mission Pharmacal Company
$49
Teva Pharmaceuticals USA, Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$46
Tempus AI, Inc
$46
AbbVie, Inc.
$43
Global Blood Therapeutics, Inc.
$42
Sirtex Medical Inc
$39
Agios Pharmaceuticals, Inc.
$38
Apellis Pharmaceuticals, Inc.
$37
PharmaEssentia USA Corporation
$31
Taiho Oncology, Inc.
$29
Puma Biotechnology, Inc.
$29
SANOFI-AVENTIS U.S. LLC
$29
ARRAY BIOPHARMA INC
$29
Pharmacyclics LLC, an AbbVie Company
$28
CTI BioPharma Corp.
$24
Mylan Pharmaceuticals Inc.
$24
Nevro Corp.
$22
Octapharma USA, Inc.
$21
Pharmacosmos Therapeutics Inc.
$19
Kite Pharma, Inc.
$18
Bio Products Laboratory USA, Inc.
$18
Rigel Pharmaceuticals, Inc.
$17
AbbVie Inc.
$17
Azurity Pharmaceuticals, Inc.
$15
Fortovia Therapeutics, Inc.
$15
Myovant Sciences Inc.
$15
Karyopharm Therapeutics Inc.
$14
TG Therapeutics, Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Blueprint Medicines Corporation
$14
Immunocore Limited
$14
Myriad Genetic Laboratories, Inc.
$14
TG THERAPEUTICS, INC.
$14
Kyowa Kirin, Inc.
$13
TOLMAR Pharmaceuticals, Inc.
$11
Lexicon Pharmaceuticals, Inc.
$11
Top 3 companies account for 29.1% of all-time payments
Associated products mentioned in payments ›
AFINITOR · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avar · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRILINTA · BRUKINSA · Balversa · CABOMETYX · CERTUS 140 MICROWAVE ABLATION SYSTEM · CHANTIX · CINVANTI · CYRAMZA · Cabometyx · Cinvanti · CitraNatal · Cresemba · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · ENHERTU · EPKINLY · ERLEADA · EXKIVITY · Empaveli · Endari · Enhertu · Erleada · FARESTON · FASLODEX · FOUNDATIONONE · FOUNDATIONONE LIQUID CDX · Fabhalta · Ferralet · Fulphila · GIVLAARI · GRANIX · Gammaplex · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NINLARO · Nplate · Nubeqa · OCTAPLAS · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Omnia · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PYRUKYND · Perjeta · Pomalyst · Prolia · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · Stivarga · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZARXIO · ZEJULA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
433
County median income
$109,028
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL AT RAHWAY
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Koduri is a mixed practice specialist, with above-average Medicare volume (top 2% in NJ), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Koduri experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Koduri performed 173,221 iron sucrose injection (venofer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Koduri receive payments from pharmaceutical companies?
Yes. Dr. Koduri received a total of $14,367 from 84 companies across 834 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koduri's costs compare to other hematology & oncology specialists in Edison?
Dr. Koduri's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koduri) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Edison
Browse hematology & oncology specialists in Edison ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology